---
title: "Top 10 HK Stock Losers (10.24)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262571518.md"
description: "SHANDONG MOLONG(00568) fell 15.71%, with a trading turnover 787.2 Million HKD, and a year-to-date rose 250.4%. TIANJIN CAPITAL(01065) fell 11.27%, with a trading turnover 166.0 Million HKD, and a year-to-date rose 38.1%. QHD PORT(03369) fell 10.76%, with a trading turnover 109.4 Million HKD, and a year-to-date rose 34.1%."
datetime: "2025-10-24T08:31:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262571518.md)
  - [en](https://longbridge.com/en/news/262571518.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262571518.md)
generator: "portal-rs"
---

# Top 10 HK Stock Losers (10.24)

Hang Seng Index has rose 0.74%, with a year-to-date rose 30.4%; Hang Seng TECH Index has rose 1.82%, with a year-to-date rose 35.6%.

SHANDONG MOLONG(00568) fell 15.71%, with a trading turnover 787.2 Million HKD, and a year-to-date rose 250.4%.

TIANJIN CAPITAL(01065) fell 11.27%, with a trading turnover 166.0 Million HKD, and a year-to-date rose 38.1%.

QHD PORT(03369) fell 10.76%, with a trading turnover 109.4 Million HKD, and a year-to-date rose 34.1%.

### Related Stocks

- [00568.HK](https://longbridge.com/en/quote/00568.HK.md)
- [01065.HK](https://longbridge.com/en/quote/01065.HK.md)
- [03369.HK](https://longbridge.com/en/quote/03369.HK.md)
- [03677.HK](https://longbridge.com/en/quote/03677.HK.md)
- [02105.HK](https://longbridge.com/en/quote/02105.HK.md)
- [00147.HK](https://longbridge.com/en/quote/00147.HK.md)
- [06110.HK](https://longbridge.com/en/quote/06110.HK.md)
- [02595.HK](https://longbridge.com/en/quote/02595.HK.md)
- [09878.HK](https://longbridge.com/en/quote/09878.HK.md)
- [09887.HK](https://longbridge.com/en/quote/09887.HK.md)

## Related News & Research

- [CLSA: China Biotech Fundamentals Remain Solid; Top Picks BEONE MEDICINES , INNOVENT BIO  and LEADS BIOLABS-B](https://longbridge.com/en/news/297994035.md)
- [Genfleet Therapeutics files HKEX next-day return disclosing share buyback at HKD 27.6 avg](https://longbridge.com/en/news/297774745.md)
- [International Business Settlement notes share surge, cites talks on potential tech-sector investment](https://longbridge.com/en/news/297169089.md)
- [Laekna enrolls first patient in China Phase I trial of cancer drug candidate LAE118](https://longbridge.com/en/news/297573070.md)
- [Laekna Starts First-Patient Phase I Trial of LAE118 and Deepens Vasque Bio Alliance](https://longbridge.com/en/news/297576055.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**